Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji-Feng Feng

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Medical Oncology|July 24, 2018
HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9Dong-Qin Chen, Chen Yu, Xue-Feng Zhang, et al.
Chinese Medical Journal|December 15, 2011
XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancerXiao-Li Zhu, Xin-Chen Sun, Bao-An Chen, et al.
Annals of Hematology|July 31, 2021
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 studyXiao-Xiao Wang, Yan Gao, Jie Jin, et al.
Chinese Medical Journal|August 14, 2012
Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemiaPei-Pei Xu, Bao-An Chen, Ji-Feng Feng, et al.
Gut|November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagyWen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Medicine|January 16, 2015
Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II studyHong-Yun Zhao, Gong-Yan Chen, Yan Huang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 25, 2003
[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
Journal of Hepatology|November 15, 2012
Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studiesYe-Wei Zhang, Jian Niu, Xiang Lu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Detection of single nucleotide polymorphisms of Jak2 gene in multiple myeloma by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry]Yue-Jiao Zhoang, Bao-An Chen, Lu Cheng, et al.
Journal of Cancer|April 15, 2021
Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancerJia-Hui Ye, Xiao-Hua Wang, Jia-Jun Shi, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|July 24, 2018
HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9Dong-Qin Chen, Chen Yu, Xue-Feng Zhang, et al.
Chinese Medical Journal|December 15, 2011
XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancerXiao-Li Zhu, Xin-Chen Sun, Bao-An Chen, et al.
Annals of Hematology|July 31, 2021
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 studyXiao-Xiao Wang, Yan Gao, Jie Jin, et al.
Chinese Medical Journal|August 14, 2012
Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemiaPei-Pei Xu, Bao-An Chen, Ji-Feng Feng, et al.
Gut|November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagyWen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Medicine|January 16, 2015
Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II studyHong-Yun Zhao, Gong-Yan Chen, Yan Huang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 25, 2003
[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
Journal of Hepatology|November 15, 2012
Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studiesYe-Wei Zhang, Jian Niu, Xiang Lu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Detection of single nucleotide polymorphisms of Jak2 gene in multiple myeloma by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry]Yue-Jiao Zhoang, Bao-An Chen, Lu Cheng, et al.
Journal of Cancer|April 15, 2021
Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancerJia-Hui Ye, Xiao-Hua Wang, Jia-Jun Shi, et al.
Pageof 11